574 related articles for article (PubMed ID: 16526819)
1. Travellers' diarrhoea: contemporary approaches to therapy and prevention.
DuPont HL
Drugs; 2006; 66(3):303-14. PubMed ID: 16526819
[TBL] [Abstract][Full Text] [Related]
2. Systematic review: prevention of travellers' diarrhoea.
DuPont HL
Aliment Pharmacol Ther; 2008 May; 27(9):741-51. PubMed ID: 18284650
[TBL] [Abstract][Full Text] [Related]
3. Systematic review: the epidemiology and clinical features of travellers' diarrhoea.
DuPont HL
Aliment Pharmacol Ther; 2009 Aug; 30(3):187-96. PubMed ID: 19392866
[TBL] [Abstract][Full Text] [Related]
4. A meta-analysis of the use of rifaximin to prevent travellers' diarrhoea.
Ng QX; Ho CYX; Shin D; Venkatanarayanan N; Chan HW
J Travel Med; 2017 Sep; 24(5):. PubMed ID: 28498921
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of rifaximin in prevention of diarrhoea in individuals travelling to south and southeast Asia: a randomised, double-blind, placebo-controlled, phase 3 trial.
Zanger P; Nurjadi D; Gabor J; Gaile M; Kremsner PG
Lancet Infect Dis; 2013 Nov; 13(11):946-54. PubMed ID: 24012319
[TBL] [Abstract][Full Text] [Related]
6. Review article: prevention and treatment of travellers' diarrhoea.
Farthing MJ
Aliment Pharmacol Ther; 1991 Feb; 5(1):15-30. PubMed ID: 1932478
[TBL] [Abstract][Full Text] [Related]
7. Travellers' diarrhoea: causes, prevention and treatment.
Lloyd R; Bennett C
Nurs Stand; 2012 Jun 6-12; 26(40):51-6; quiz 58. PubMed ID: 22848971
[TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of the antibacterial rifaximin in the treatment of travellers' diarrhoea.
Ericsson CD
Drug Saf; 2006; 29(3):201-7. PubMed ID: 16524320
[TBL] [Abstract][Full Text] [Related]
9. Prevention and treatment of traveler's diarrhea: a clinical pharmacological approach.
Scarpignato C; Rampal P
Chemotherapy; 1995; 41 Suppl 1():48-81. PubMed ID: 7671647
[TBL] [Abstract][Full Text] [Related]
10. Use of antimicrobial agents for treatment and prevention of travellers' diarrhoea in the face of enhanced risk of transient fecal carriage of multi-drug resistant enterobacteriaceae: setting the stage for consensus recommendations.
DuPont HL; Steffen R
J Travel Med; 2016 Jun; 23(6):. PubMed ID: 27503854
[TBL] [Abstract][Full Text] [Related]
11. Medications for the prevention and treatment of travellers' diarrhea.
Taylor DN; Hamer DH; Shlim DR
J Travel Med; 2017 Apr; 24(suppl_1):S17-S22. PubMed ID: 28520998
[TBL] [Abstract][Full Text] [Related]
12. Travellers' diarrhoea.
Ericsson CD
Int J Antimicrob Agents; 2003 Feb; 21(2):116-24. PubMed ID: 12615374
[TBL] [Abstract][Full Text] [Related]
13. Review article: rifaximin, a minimally absorbed oral antibacterial, for the treatment of travellers' diarrhoea.
Layer P; Andresen V
Aliment Pharmacol Ther; 2010 Jun; 31(11):1155-64. PubMed ID: 20331580
[TBL] [Abstract][Full Text] [Related]
14. Travellers' diarrhoea.
Heather CS
BMJ Clin Evid; 2015 Apr; 2015():. PubMed ID: 25928418
[TBL] [Abstract][Full Text] [Related]
15. Travellers' diarrhoea: prevention by chemoprophylaxis.
Turner AC
Scand J Gastroenterol Suppl; 1983; 84():106-10. PubMed ID: 6227078
[TBL] [Abstract][Full Text] [Related]
16. [The management of travellers' diarrhoea].
Gétaz L; Chappuis F; Loutan L
Med Mal Infect; 2007 Dec; 37(12):781-6. PubMed ID: 17997250
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of rifaximin against clinical isolates of Escherichia coli and other enteropathogenic bacteria isolated from travellers returning to the UK.
Hopkins KL; Mushtaq S; Richardson JF; Doumith M; de Pinna E; Cheasty T; Wain J; Livermore DM; Woodford N
Int J Antimicrob Agents; 2014 May; 43(5):431-7. PubMed ID: 24661532
[TBL] [Abstract][Full Text] [Related]
18. Current and future developments in travelers' diarrhea therapy.
Koo HL; DuPont HL
Expert Rev Anti Infect Ther; 2006 Jun; 4(3):417-27. PubMed ID: 16771619
[TBL] [Abstract][Full Text] [Related]
19. Travellers' diarrhoea. Which antimicrobial?
DuPont HL
Drugs; 1993 Jun; 45(6):910-917. PubMed ID: 7691498
[TBL] [Abstract][Full Text] [Related]
20. Locals get travellers' diarrhoea too: risk factors for diarrhoeal illness and pathogenic Escherichia coli infection across an urban-rural gradient in Ecuador.
Smith SM; Montero L; Paez M; Ortega E; Hall E; Bohnert K; Sanchez X; Puebla E; Endara P; Cevallos W; Trueba G; Levy K
Trop Med Int Health; 2019 Feb; 24(2):205-219. PubMed ID: 30444557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
